pyrroloquinoline
Small moleculeexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 27, 2024 (NCT06431113)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06748989 | N/A | Feb 1, 2025 | FEMPHARMA Kft. |
| NCT06245083 | Early Phase 1 (Phase 1) | Dec 31, 2024 | University of Oklahoma |
| NCT07148726 | N/A | Sep 1, 2024 | University of Padova |
| NCT06431113 | Phase 3 | Jan 27, 2024 | University of Naples Frederico II, University of Pavia, University of Roma La Sapienza |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| FEMPHARMA Kft. | For profit | 1 | 1 | 1 | 2025 |
| University of Naples Frederico II | Academic/Hospital | 1 | 0 | 1 | 2024 |
| University of Oklahoma | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Padova | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Pavia | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Roma La Sapienza | Academic/Hospital | 1 | 0 | 1 | 2024 |
6 organizations
Page 1 / 1